| Title |
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update
|
|---|---|
| Published in |
Journal of Clinical Oncology, June 2018
|
| DOI | 10.1200/jco.2018.79.2697 |
| Pubmed ID | |
| Authors |
Sharon H Giordano, Sarah Temin, Sarat Chandarlapaty, Jennie R Crews, Francisco J Esteva, Jeffrey J Kirshner, Ian E Krop, Jennifer Levinson, Nancy U Lin, Shanu Modi, Debra A Patt, Jane Perlmutter, Naren Ramakrishna, Eric P Winer, Nancy E Davidson |
X Demographics
The data shown below were collected from the profiles of 62 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 22 | 35% |
| Spain | 4 | 6% |
| United Kingdom | 2 | 3% |
| Mexico | 1 | 2% |
| Colombia | 1 | 2% |
| Israel | 1 | 2% |
| United Arab Emirates | 1 | 2% |
| Venezuela, Bolivarian Republic of | 1 | 2% |
| India | 1 | 2% |
| Other | 6 | 10% |
| Unknown | 22 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 36 | 58% |
| Practitioners (doctors, other healthcare professionals) | 18 | 29% |
| Scientists | 6 | 10% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 235 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 235 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 32 | 14% |
| Student > Ph. D. Student | 27 | 11% |
| Researcher | 27 | 11% |
| Student > Bachelor | 21 | 9% |
| Student > Postgraduate | 17 | 7% |
| Other | 43 | 18% |
| Unknown | 68 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 76 | 32% |
| Pharmacology, Toxicology and Pharmaceutical Science | 25 | 11% |
| Biochemistry, Genetics and Molecular Biology | 20 | 9% |
| Agricultural and Biological Sciences | 6 | 3% |
| Economics, Econometrics and Finance | 6 | 3% |
| Other | 27 | 11% |
| Unknown | 75 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 66. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2023.
All research outputs
#656,172
of 25,837,817 outputs
Outputs from Journal of Clinical Oncology
#1,470
of 22,362 outputs
Outputs of similar age
#14,142
of 344,761 outputs
Outputs of similar age from Journal of Clinical Oncology
#33
of 553 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,362 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,761 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 553 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.